ANI Pharmaceuticals | ANIP - Des Atouts





Des Atouts Changement Date
AbbVie USD 135.12B 1.35B 2026-06
ANI Pharmaceuticals USD 1.49B 72.14M 2026-06
Aurora Cannabis CAD 601.09M 174.2M 2026-03
Canopy Growth CAD 1.12B 12.54M 2026-03
Eli Lilly USD 142.28B 25.71B 2026-06
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Heron Therapeutics USD 252.26M 6.05M 2026-06
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Novartis USD 118.53B 7.58B 2026-03
Omeros USD 200.57M 34.59M 2025-06
Perrigo USD 7.61B 373.8M 2026-06
Sun Pharmaceuticals INR 1.09T 50.79B 2026-03
Teva Pharmaceutical Industries USD 39.86B 183M 2026-06